Hart, R.Doherty, D.Norman, R.Franks, S.Dickinson, J.Hickey, M.Sloboda, D.2010-11-112010-11-112010Fertility and Sterility, 2010; 94(3):1118-11210015-02821556-5653http://hdl.handle.net/2440/61674Polycystic ovarian syndrome (PCOS) is a common endocrine disorder in adolescents, with potentially significant lifelong consequences. This prospective study set out to determine if the investigators could derive a threshold value of antimullerian hormone (AMH) that would predict its presence according to two internationally recognized definitions using a simple measurement, avoiding more extensive and potentially more invasive investigations. The study failed to demonstrate, in a general adolescent population, that serum AMH is a reliable predictor of PCO morphology or for the presence of PCOS.enCopyright © 2010 American Society for Reproductive Medicine. Published by Elsevier Inc.OvaryHumansOvarian CystsPolycystic Ovary SyndromeDiagnostic Techniques, EndocrineBody Mass IndexOrgan SizeSensitivity and SpecificityCohort StudiesUp-RegulationAdolescentFemaleAnti-Mullerian HormoneBiomarkersSerum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS)Journal article002010007010.1016/j.fertnstert.2009.11.0020002804079000532-s2.0-7795556817233835Norman, R. [0000-0002-3118-3896]